Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michaud, S. E.
Right arrow Articles by Renier, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michaud, S. E.
Right arrow Articles by Renier, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:660-666, 2001
© 2001 by the American Diabetes Association, Inc.

Direct Regulatory Effect of Fatty Acids on Macrophage Lipoprotein Lipase

Potential Role of PPARs

Sophie Élise Michaud1, and Geneviève Renier2

1 Department of Nutrition, University of Montreal
2 Centre Hospitalier de l’Université de Montréal Research Center, Notre-Dame Hospital, Montreal, Quebec, Canada

Atherosclerosis is a major complication of type 2 diabetes. The pathogenesis of this complication is poorly understood, but it clearly involves production in the vascular wall of macrophage (Mo) lipoprotein lipase (LPL). Mo LPL is increased in human diabetes. Peripheral factors dysregulated in diabetes, including glucose and free fatty acids (FAs), may contribute to this alteration. We previously reported that high glucose stimulates LPL production in both J774 murine and human Mo. In the present study, we evaluated the direct effect of FAs on murine Mo LPL expression and examined the involvement of peroxisome proliferator–activated receptors (PPARs) in this effect. J774 Mo were cultured for 24 h with 0.2 mmol/l unsaturated FAs (arachidonic [AA], eicosapentaenoic [EPA], and linoleic acids [LA]) and monounsaturated (oleic acid [OA]) and saturated FAs (palmitic acid [PA] and stearic acid [SA]) bound to 2% bovine serum albumin. At the end of this incubation period, Mo LPL mRNA expression, immunoreactive mass, activity, and synthetic rate were measured. Incubation of J774 cells with LA, PA, and SA significantly increased Mo LPL mRNA expression. In contrast, exposure of these cells to AA and EPA dramatically decreased this parameter. All FAs, with the exception of EPA and OA, increased extra- and intracellular LPL immunoreactive mass and activity. Intracellular LPL mass and activity paralleled extracellular LPL mass and activity in all FA-treated cells. In Mo exposed to AA, LA, and PA, an increase in Mo LPL synthetic rate was observed. To evaluate the role of PPARs in the modulatory effect of FAs on Mo LPL gene expression, DNA binding assays were performed. Results of these experiments demonstrate an enhanced binding of nuclear proteins extracted from all FA-treated Mo to the peroxisome proliferator–response element (PPRE) consensus sequence of the LPL promoter. PA-, SA-, and OA-stimulated binding activity was effectively diminished by immunoprecipitation of the nuclear proteins with anti–PPAR-{alpha} antibodies. In contrast, anti–PPAR-{gamma} antibodies only significantly decreased AA-induced binding activity. Overall, these results provide the first evidence for a direct regulatory effect of FAs on Mo LPL and suggest a potential role of PPARs in the regulation of Mo LPL gene expression by FAs.


Abbreviations: AA, arachidonic acid; BSA, bovine serum albumin; DMEM, Dulbecco’s minimal essential medium; DTT, dithiothreitol; EPA eicosapentaenoic acid; FA, fatty acid; FAAR, FA-activated receptor; FCS, fetal calf serum; LA, linoleic acid; LPL, lipoprotein lipase; Mo, macrophage; OA, oleic acid; PA, palmitic acid; PBS, phosphate-buffered salt solution; PKC, protein kinase C; PMSF, phenylmethylsulfonyl fluoride; PPAR, peroxisome proliferator–activated receptor; PPRE, peroxisome proliferator–responsive element; SA, stearic acid; TBS, Tris-buffered saline


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. Nielsen, L. Grontved, H. G. Stunnenberg, and S. Mandrup
Peroxisome Proliferator-Activated Receptor Subtype- and Cell-Type-Specific Activation of Genomic Target Genes upon Adenoviral Transgene Delivery
Mol. Cell. Biol., August 1, 2006; 26(15): 5698 - 5714.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Maingrette and G. Renier
Linoleic Acid Increases Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Expression in Human Aortic Endothelial Cells
Diabetes, May 1, 2005; 54(5): 1506 - 1513.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M.-C. Beauchamp, S.-E. Michaud, L. Li, M. R. Sartippour, and G. Renier
Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression
J. Lipid Res., September 1, 2004; 45(9): 1749 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. H. Huang, D. Gu, and T. Mazzone
Oleic Acid Modulates the Post-translational Glycosylation of Macrophage ApoE to Increase Its Secretion
J. Biol. Chem., July 9, 2004; 279(28): 29195 - 29201.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Serri, L. Li, F. Maingrette, N. Jaffry, and G. Renier
Enhanced Lipoprotein Lipase Secretion and Foam Cell Formation by Macrophages of Patients with Growth Hormone Deficiency: Possible Contribution to Increased Risk of Atherogenesis?
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 979 - 985.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Maingrette and G. Renier
Leptin Increases Lipoprotein Lipase Secretion by Macrophages: Involvement of Oxidative Stress and Protein Kinase C
Diabetes, August 1, 2003; 52(8): 2121 - 2128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. A. Francis, J.-S. Annicotte, and J. Auwerx
PPAR-{alpha} effects on the heart and other vascular tissues
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H1 - H9.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M.-C. Beauchamp and G. Renier
Homocysteine Induces Protein Kinase C Activation and Stimulates c-Fos and Lipoprotein Lipase Expression in Macrophages
Diabetes, April 1, 2002; 51(4): 1180 - 1187.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. R. Hughes, T. S. Tengku-Muhammad, S. A. Irvine, and D. P. Ramji
A Novel Role of Sp1 and Sp3 in the Interferon-gamma -mediated Suppression of Macrophage Lipoprotein Lipase Gene Transcription
J. Biol. Chem., March 22, 2002; 277(13): 11097 - 11106.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. O. Pentikainen, R. Oksjoki, K. Oorni, and P. T. Kovanen
Lipoprotein Lipase in the Arterial Wall: Linking LDL to the Arterial Extracellular Matrix and Much More
Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 211 - 217.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Taniguchi, M. Fukushima, M. Sakai, K. Hama, K. Sakaguchi, N. Nezumi, H. Kishimoto, T. Watanabe, K. Matsumoto, S. Nagasaka, et al.
Serum Nonesterified Fatty Acids Are Increased in Nonobese Japanese Type 2 Diabetic Patients With Microalbuminuria
Diabetes Care, October 1, 2001; 24(10): 1847 - 1849.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. Taniguchi, M. Sakai, S. Teramura, M. Fukushima, K. Hama, K. Marumoto, N. Nezumi, T. Yoshida, S. Nagasaka, R. Hayashi, et al.
Serum Nonesterified Fatty Acids Are Related With Carotid Atherosclerotic Plaque in Nonobese Nonhypertensive Japanese Type 2 Diabetic Patients
Diabetes Care, August 1, 2001; 24(8): 1505 - 1507.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.